Âé¶¹´«Ã½

    Advertisement

    We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

    In the last 6 hours
    PR Newswire (Press Release)07:05
    Yesterday
    Korea Biomedical Review20:36 4-Aug-25
    Armagh I10:17 4-Aug-25
    PR Newswire (Press Release)06:10 4-Aug-25
    In the last 7 days
    Manufacturing Chemist03:04 1-Aug-25
    Business Wire (Press Release)10:05 31-Jul-25
    ecancer09:55 31-Jul-25
    Pharmaceutical Technology07:07 30-Jul-25
    Nature.com07:05 30-Jul-25
    Business Wire (Press Release)09:07 29-Jul-25
    Pharmafile07:51 29-Jul-25
    Business Wire (Press Release)02:00 29-Jul-25
    In the last month
    Drug Target Review03:35 28-Jul-25
    PR Newswire (Press Release)19:40 27-Jul-25
    BioSpectrum Asia14:35 27-Jul-25
    Korea Biomedical Review01:35 25-Jul-25
    STAT06:36 23-Jul-25
    ecancer11:20 22-Jul-25
    Business Wire (Press Release)09:10 22-Jul-25
    Korea Biomedical Review02:07 21-Jul-25
    Technology Networks09:23 17-Jul-25
    Business Wire (Press Release)08:07 17-Jul-25
    The Daily Pennsylvanian22:10 16-Jul-25
    Drug Target Review03:38 16-Jul-25
    ecancer11:06 15-Jul-25
    ecancer10:56 15-Jul-25
    Labiotech09:05 15-Jul-25
    British Society for Haematology04:34 15-Jul-25
    Newswise (Press Release)09:09 14-Jul-25
    Behavioural and Social Sciences at Nature Research04:46 14-Jul-25
    Drug Target Review03:38 14-Jul-25
    PR Newswire (Press Release)20:00 13-Jul-25
    PR Newswire (Press Release)08:21 9-Jul-25
    pharmaphorum08:03 9-Jul-25
    Scrip Pharma Intelligence09:35 8-Jul-25
    Business Wire (Press Release)00:05 8-Jul-25
    PR Newswire (Press Release)09:35 7-Jul-25
    view more headlines
    5 Aug 07:05

    About our CAR-T news

    Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.